Ketamine: Stimulating antidepressant treatment?

Gin S. Malhi, Yulisha Byrow, Frederick Cassidy, Andrea Cipriani, Koen Demyttenaere, Mark A. Frye, Michael Gitlin, Sidney H. Kennedy, Terence A. Ketter, Raymond W. Lam, Rupert McShane, Alex J. Mitchell, Michael J. Ostacher, Sakina J. Rizvi, Michael E. Thase, Mauricio Tohen

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

The appeal of ketamine - in promptly ameliorating depressive symptoms even in those with non-response - has led to a dramatic increase in its off-label use. Initial promising results await robust corroboration and key questions remain, particularly concerning its long-term administration. It is, therefore, timely to review the opinions of mood disorder experts worldwide pertaining to ketamine's potential as an option for treating depression and provide a synthesis of perspectives - derived from evidence and clinical experience - and to consider strategies for future investigations.

Original languageEnglish (US)
Pages (from-to)E5-E9
JournalBJPsych Open
Volume2
Issue number3
DOIs
StatePublished - 2016

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Ketamine: Stimulating antidepressant treatment?'. Together they form a unique fingerprint.

  • Cite this

    Malhi, G. S., Byrow, Y., Cassidy, F., Cipriani, A., Demyttenaere, K., Frye, M. A., Gitlin, M., Kennedy, S. H., Ketter, T. A., Lam, R. W., McShane, R., Mitchell, A. J., Ostacher, M. J., Rizvi, S. J., Thase, M. E., & Tohen, M. (2016). Ketamine: Stimulating antidepressant treatment? BJPsych Open, 2(3), E5-E9. https://doi.org/10.1192/bjpo.bp.116.002923